Menu
Not yet recruiting NCT07423416

Validation of the Modified Cognitive Assessment Scale (MoCA Blind) for the Diagnosis of Postoperative Neurocognitive Disorders in Patients With Corneal Pathology in Russia.

Observational Postoperative Neurocognitive Disorders

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Neurocognitive testing.
Who it may be relevant to
Registry conditions: Postoperative Neurocognitive Disorders. Basic parameters: 18 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Long-term observation has shown that patients with visual impairment often develop cognitive impairments. Due to the fact that patients who are planning to undergo corneal transplantation may have initial cognitive deficits, assessing cognitive function is an important aspect of work for both the anesthesiologist and the operating surgeon. Given the high significance of assessing cognitive function after anesthesia in ophthalmic surgery patients, it is relevant to adapt and validate the Russian version of the MoCA Blind test for subsequent use in clinical practice.

Interventions

  • Diagnostic test Neurocognitive testing
    The psychometric properties of the Russian version of the MoCA Blind scale were evaluated according to the following parameters: reliability (reproducibility and internal consistency), validity (content and construct), and sensitivity.

Primary outcome measures

  • postoperative neurocognitive disorders [Time frame: From the moment of inclusion in the study until the end of treatment 90 days later]

Eligibility criteria

Inclusion criteria

  • patients with corneal pathology, including burns, ulcers, dystrophies, and keratoectasia, as well as those with a history of corneal injuries
  • physical status of I-III on the ASA scale.

Exclusion criteria

  • children
  • patients with sensorineural hearing loss
  • patients with chronic cerebrovascular disorders
  • patients with initially high levels of anxiety and depressive symptoms
  • patients with severe cognitive impairments.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07423416 · SNF1 · № 143 01.01.2026

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗